331 filings
8-K
PFE
Pfizer Inc.
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
PFE
Pfizer Inc.
10 Jan 24
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
4:38pm
8-K/A
PFE
Pfizer Inc.
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
PFE
Pfizer Inc.
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
PFE
Pfizer Inc.
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
ofiqxba45m
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
o759q2kiapiir
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
hs1f6
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
lpqks qgm14wv4l
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
8-K
gciqggj
27 Jul 23
Departure of Directors or Certain Officers
4:11pm
8-K
4z3imy es2ko1kqdz
19 May 23
Other Events
4:26pm
8-K
tuv6pmu3q2
15 May 23
Other Events
6:25am
8-K
yz2 eyax8b5qjsu2
2 May 23
Pfizer Reports First-Quarter 2023 Results
8:05am
8-K
kinl7m7 paazzhoaow4j
1 May 23
Submission of Matters to a Vote of Security Holders
9:39am
8-K
ll5pwanq1ezdkm903zmn
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
8:29am
8-K
owwfw477tj0y44
21 Feb 23
Other Events
4:17pm
8-K
dh9zxp9pfwael4fk ixk
31 Jan 23
Pfizer Reports Record Full-year 2022 Results and Provides Full-year 2023 Financial Guidance
8:11am
8-K
jpmhryh9k0uwge
13 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:19pm
8-K
210eo4 6qvn551rtt
1 Nov 22
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
8:11am
8-K
jhzs mdk8anm
28 Jul 22
Pfizer Reports Second-quarter 2022 Results
8:09am